The Triumphs of Brian Bonar in the Financial World

February 27, 2017 – The CEO of Trucept, Brian Bonar has been working hard to make his information more accessible to the public. To get to know Brian a little better, check out his About.me profile.

In 2010, the CEO of Dalrada Financial Group, Brain Bonar scooped the Executive of the Year in Finance in the Cambridge Who’s Who annual list. Every year, the selection committee picks two females and two males for the executive of the year honor, depending on the academic accomplishments, leadership skills, and professional achievements. Learn more about Brian Bonar: http://www.prnewswire.com/news-releases/imaging-technologies-ceo-brian-bonar-interviewed-on-wallstreetreportercom-74409637.html

Brian Bonar has been in the financial sector for over 30 years and has amassed a wealth of knowledge during that time. Under the leadership of Bonar, Dalrada Financial has cemented an impressive legacy in the field of finance.

Dalrada

Dalrada Financial Group provides employee programs for different companies across the nation with the objective of increasing business efficiency. The entity has enjoyed significant success by customizing services that include insurance, business process outsourcing, and finance that cater to the needs of a particular client.

Under Bonar’s command, Dalrada has helped numerous clients manage their finances and protect their assets. The growth of the company and its commitment to providing businesses with top-of-the-line aftermarket products is one that mirrors the passion that Bonar has shown throughout his career.

Qualifications

Bonar got his undergraduate degree from the University of Strathclyde in Glasgow, and a graduate degree and doctorate from Stafford University in the UK. Brian Bonar was the Director of Technology Sales for the period between August 1992 and April 1994. His dedication and work ethic saw him rise the ranks with one promotion after another.

He was promoted to Dalrada’s Vice President, Sales and Marketing in April 1994, a position he held for only a few months as he became the Executive Vice President in September of that year. Bonar served as the Director of Dalrada from 1995 until 1997 when he was the President as well as the Chief Operating Officer. Brian Bonar took the reins of CEO of Dalrada Financial in 1998, and 1999 was when he was declared as the Chairman of the Board.  Read more: The New Frontier

Bonar’s Vast Experience

The Scottish financial expert has held positions in various institutions in the course of his illustrious career. Besides his positions at Dalrada Financial, he is also presently the CEO and Chairman of Trucept Inc., formerly Star-Tek Solutions, which is a title he has held since 2010.

He is also the CFO and acting CEO of Amanda Co. Inc. Before that, he was CFO, Treasurer, and Secretary. Bonar was also Benzier Systems’ VP of Worldwide Sales and Marketing since 1991 to 1992. From 1990 to 1991, Adaptech Inc. had him as its Worldwide Sales Manager. Other companies that Brian Boner has served in different capacities include; Rastek Corporation, QMS, Inc. The Solvis Group, Inc, Greenland Corp, and Allegiant Professional Business Services, Inc, just to name a few.

The Distinguised Career Of Clay Siegall

Clay Siegall is one of the co-founders of a company known as Seattle Genetics. The company was founded in 1998 and Siegall is the CEO, President and sits on the Board of Directors. The portfolio Seattle Genetics has developed is quite diverse. It is both preclinical and clinical candidates and targets autoimmune diseases and numerous types of cancer.

 

Seattle Genetics leads the industry in antibody technologies. The most prominent technology is an antibody drug conjugate called ADC. With Dr. Siegall’s guidance in raising capitol he has helped to secure over $300 million. This was through private and public financing including the original offering made in 2001. The company has also been a part of strategic collaborations. This includes an agreement with Genentech on an exclusive worldwide basis. The contract was for SGN-40 and the total value exceeded $860 million. There were also numerous collaborations with ADC including CuraGen, Progenics, Medimmune and Bayer. These collaborations came to a total of well over $65 million since the year 2001.

 

Before Dr. Siegall co-founded Seattle Genetics he worked with Bristol-Myers Squibb Pharmaceutical. He was with this Research Institute between the years of 1991 and 1997. Dr. Siegall worked with the National Institutes of Health as well as the National Cancer Institute between the years of 1988 and 1991. Dr. Siegall sits on the Board for Alder BioPharmaceuticals. This company is biotechnological and private. He is also on the Board of Directors for Biomedical Association in Washington. Dr. Siegall additionally sits on the Board for Fred Hutchinson Cancer Research.

 

Dr. Clay Siegall was schooled at the George Washington University where he received his Ph.D. in the field of genetics. He earned his B.S. in Zoology when he attened the University of Maryland.

The History Of Stephen Murray

Stephen Murray is a philanthropist and a private equity investor. Murray was born in August 1962. He lived for 52 years before passing away in March 2015. Stephen was the Chief Executive Officer and President at CCMP Capital throughout his career. The firm is privately owned. It is involved in buyout and growth of equity transactions.

Stephen is a graduate of Boston College. He holds a degree in Economics. Stephen also went to Columbia Business School to get a Masters in Business Administration. Murray joined Manufacturers Hanover Corporation for a credit analyst training program in 1984. He later went to MH Equity Corporation. Chemical Bank bought Manufacturers Hanover Corporation in 1991. Stephen joined JP Morgan Partners as the head of buyout business in 2005. Murray became the co-founder of CCMP Capital in August 2006. CCMP Capital is a spinout of JP Morgan Chase. It carried the equity team of buyout and growth from the previous company.

Read more:
Stephen Murray, Ex-CCMP Chief Who Built LBO Firm, Dies at 52
CCMP Capital Advisors Gets Backing to Resume Investing From Fund

Stephen Murray was announced as the CEO of CCMP Capital in 2007. This position put him in a good place to exercise the skills and experience he had gained while working in other former firms. Stephen was also able to serve as a board member in a number of large enterprises such as Cabela’s, Aramark, AMC Entertainment, Generac Power Systems, among others.

Stephen Murray supported The Foodbank of Lower Fairfield Country, the Make-A-Wish Foundation of Metro New York, and Columbia Business School. It was announced that the greatest philanthropist Stephen Murray had passed away on 12th March 2015. This was a shock to many people since the advisor had just left CCMP Capital the previous month.

The spokesperson of CCMP Capital released an email that confirmed the death of Stephen Murray. The firm said that they were very saddened by the passing away of Stephen and that they would miss him. They also confirmed that the reason why Murray had left the firm was because of health problems. They further said that he needed a break to seek medical attention. Murray left behind his wife and their four sons. CCMP Capital referred to Stephen as a great deal maker. CCMP Capital managed to invest in some investments including Quiznos Corp, Warner Chilcott Plc, and Cabela’s Inc while Stephen was serving as the Chief Executive Officer of CCMP Capital.

Read more from Stephen Murray on Institutional Investor
Follow Stephen Murray on Crunchbase